Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
Clinical trial NCT05325528 · UNKNOWN
Trial details
- NCT number
- NCT05325528
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-10
- Primary completion
- 2025-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.